Dermatitis, Eczematous Completed Phase 3 Trials for Cetirizine (DB00341)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00375713Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and EczemaTreatment